✦ LIBER ✦

A statistical view of clinical trials in chronic hepatitis B

✍ Scribed by Burke, C.A.

Book ID: 122129091
Publisher: Elsevier Science
Year: 1986
Tongue: English
Weight: 388 KB
Volume: 3
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(86)80130-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Controlled clinical trial of acyclovir i

Controlled clinical trial of acyclovir in chronic hepatitis B virus infection

✍ Dr. Graeme J. M. Alexander; Elizabeth A. Fagan; John E. Hegarty; Adrian L. W. F. 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 470 KB 👁 1 views

A randomised, controlled trial comparing acyclovir, 45 mg/kg/day as a continuous IV infusion for 28 days, with no other therapy, was carried out in 30 stable HBsAg carriers seropositive for HBeAg for more than 6 months. Twenty-eight had hepatitis B virus DNA-polymerase activity and/or hepatitis B vi

Assessing evidence from clinical trials

Assessing evidence from clinical trials in chronic hepatitis C

✍ B. R. Bacon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Clinical importance of serum hepatitis B

Clinical importance of serum hepatitis B surface antigen levels in chronic hepatitis B

✍ S. Togo; M. Arai; A. Tawada; T. Chiba; T. Kanda; K. Fujiwara; F. Imazeki; O. Yok 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 701 KB

Statistical controversies in the design

Statistical controversies in the design of clinical trials—Some personal views

✍ Brown, Byron W. 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 999 KB

Lymphoblastoid interferon in controlled

Lymphoblastoid interferon in controlled trials of chronic hepatitis B virus infection

✍ Stephanos J. Hadziyannis 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 432 KB 👁 2 views

Clinical utility of hepatitis B surface

Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: A review

✍ Yun-Fan Liaw 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

This clinically relevant review focuses on recent findings concerning hepatitis B surface antigen (HBsAg) quantitation in untreated patients and treated patients with chronic hepatitis B. Recent studies and emerging data have shown that both HBsAg and hepatitis B virus (HBV) DNA levels decline durin